Skip this news: Testing is ongoing for site performance

Planned international expansion for one of the world's leading independent vitamin, mineral and supplement businesses, with a presence in over 70 countries

London - July 24, 2026 - 2026: Bain Capital, a leading global private investment firm, today announced that it has agreed to acquire Vitabiotics, the UK's No.1 Vitamin Company*, including its UK operations and the wider VB Group** (including Meyer Organics in India, and its operations in Africa, including VB Egypt), marking a significant milestone in Vitabiotics' 55-year history and signalling the next phase of planned rapid international growth and expansion.

The transaction brings together one of the world's leading healthcare and consumer investors with one of the most recognised independent vitamins, minerals and supplements businesses globally, creating a platform for accelerated international growth.

The UK will remain central to Vitabiotics' brand, innovation, and category leadership. There will be no immediate changes to day-to-day operations, and the company will continue to focus on delivering for customers, partners and consumers, while investing in areas including digital capabilities, e-commerce, international distribution, supply chain resilience and new product development.

Given Vitabiotics' global footprint, the investment will be led by Bain Capital's Asia Private Equity team and supported by the firm's global platform. Bain Capital will bring local market knowledge in India, together with sector expertise, portfolio resources and global capabilities, to support Vitabiotics as it continues to scale its brands, strengthen its international platform and invest in long-term growth within key markets such as MENA and China.

Vitabiotics was founded in 1971 by visionary scientist and entrepreneur, Professor Kartar Lalvani OBE, who pioneered the nutraceutical field and innovative science-based formulas, leading to whole new categories of supplements and sector-leading brands supporting specific health and life-stage needs, resulting in a unique portfolio of sector-leading products, including several household names.

Over the last decade under the leadership of his son, Tej Lalvani, Group Chief Executive Officer, the business has significantly accelerated its growth and leadership through product launches and partnerships. Having dedicated more than 30 years to working in the business, Tej Lalvani has played a central role in transforming Vitabiotics into one of the world's leading independent science-led nutraceutical companies. Outside Vitabiotics, he is widely recognised as one of the UK's leading entrepreneurs and as a Dragon on BBC TV's Dragons' Den. As founder of the Group and in recognition of his life-time contribution and leadership in the supplement sector, Professor Kartar Lalvani will assume the honorary role of Chairman Emeritus on completion of the transaction. Professor Kartar Lalvani's elder son, Professor Ajit Lalvani, has contributed his medical and scientific expertise to the business as non-executive director over three decades, alongside his distinguished clinical academic career.

The Vitabiotics Group has built leading positions across several of the world's most attractive VMS markets, including India, China, Egypt and the wider MENA region, supported by a unique combination of consumer trust, healthcare professional credibility and local market expertise. As the UK's leading vitamin company, its portfolio of trusted brands includes Pregnacare, Perfectil, Wellman, Wellwoman, Osteocare, and the Ultra range, supported by strong consumer trust, healthcare professional credibility and a growing international presence.

Tej Lalvani, Group Chief Executive Officer of Vitabiotics, said: "This marks a defining moment in Vitabiotics' journey. I'm incredibly grateful to have had the opportunity to build on my father's vision to harness the power of science and nutrition to improve everyday health and, together with our exceptional team, help transform Vitabiotics from a British family business into one of the world's most trusted vitamin and wellness companies.

This direction is not about changing who we are; it is about accelerating what we can become. With Bain Capital's global expertise and investment behind us, we have a unique opportunity to expand internationally, accelerate our innovation and take our trusted brands to millions more consumers, while staying true to the science, quality and values that have defined Vitabiotics for more than 55 years.

Pawan Singh, a Partner at Bain Capital, said: "Vitabiotics is exactly the type of business we support: a trusted, science-led brand platform with category leadership, strong healthcare professional credibility and meaningful presence across the UK, India, the Middle East, Africa and China. Our India team has deep experience partnering with healthcare and consumer businesses, and we look forward to supporting Vitabiotics' next phase of growth."

Rishi Mandawat, a Partner at Bain Capital added: "We see a compelling opportunity to help Vitabiotics build on its UK leadership and strengthen its global platform. Across Bain Capital, we will bring sector expertise, portfolio resources and local market knowledge to support investment in innovation, e-commerce, international distribution and operational capability."

Completion of the transaction remains subject to applicable closing conditgions, including customary regulatory approvals. Houlihan Lokey acted as exclusive corporate finance advisor to the selling party, advising on all aspects of the preparation, structuring, and negotiation of the transaction. Macfarlanes acted as lead legal adviser to the selling party, advising on all legal aspects of the sale and coordinating a large cross-border team. Rothschild & Co. acted as exclusive corporate finance adviser to Bain Capital. Kirkland & Ellis acted as lead legal adviser to Bain Capital, and Khaitan & co. acte4d as co-counsel advising Bain Capital on Indian law aspects of the transaction.

ENDS

About Bain Capital

Founded in 1984, Bain Capital is one of the world's leading private investment firms. We are committed to creating lasting impact for our investors, portfolio companies, and the communities in which we live. As a private partnership, we lead with conviction and a culture of collaboration, advantages that enable us to innovate investment approaches, unlock opportunities, and create exceptional outcomes. Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. In these focus areas, we bring deep sector expertise and wide-ranging capabilities. We have 24 offices on four continents, more than 1,900 employees, and approximately $225 billion in assets under management. To learn more, visit https://www.baincapital.com. Follow @BainCapital on LinkedIn and X (Twitter).

About Vitabiotics

Vitabiotics' mission is to empower wellness and healthy living through innovation in nutritional healthcare. The company has pioneered advances in nutritional healthcare for 55 years, with a portfolio that includes some of Britain's leading and most trusted supplement brands such as Perfectil, Pregnacare, Wellman, Wellwoman and Menopace.

Vitabiotics is the leading British nutraceutical company founded in 1971 by Professor Kartar Lalvani, with a heritage deeply rooted in family entrepreneurship and scientific research. Built on a foundation of clinical insight into nutritional science, the company developed some of the UK's most trusted supplement brands, including Perfectil, Pregnacare, Wellman, Wellwoman, and Menopace. It has grown into a category-defining business in vitamins and mineral-based food supplements, with products spanning key health areas and life stages, including pregnancy, men's and women's health, beauty, and family nutrition.

In 2013, Vitabiotics became the UK's largest vitamin company by sales value, reflecting its strong market position and sustained consumer trust.

As the UK's No.1 vitamin company *, Vitabiotics UK exports to over 70 countries worldwide. Alongside its international export business, the Group has established operations in key global markets including India, China, Egypt and West Africa, reflecting its evolution into a leading international nutritional healthcare company. Vitabiotics is the only vitamin company to have received the Queen's Award for Enterprise on four occasions, including twice for Innovation (in 2013 for Pregnacare and in 2018 for Perfectil). Vitabiotics also supports ongoing research and original clinical trials in collaboration with universities and leading medical centres in the UK and internationally.

About Professor Kartar Lalvani OBE

Professor Kartar Lalvani's Doctorate of Science in Medicinal Chemistry (University of Bonn) underpinned his mission to transform preventive healthcare through scientifically formulated vitamins and minerals. At a time when supplementation was often dismissed as unnecessary, he founded Vitabiotics, UK (1971) and Meyer Organics, India (1982) to combine research-led innovation, pharmaceutical-grade quality manufacturing and clinical validation. He appointed his former mentor from King's College London, the renowned Professor Arnold Beckett OBE, as Vitabiotics' first Chairman (see picture). Professor Lalvani's entrepreneurial talent drove innovation across the whole product development process, from patented formulations to unique brand names, product design and marketing. Now in his 95th year, his many accolades include Ernst & Young Master Entrepreneur of the Year (2008), Honorary Professorship of the University of Franche-Comte, France (2014), and the Lifetime Achievement Award of the Federation of Obstetricians and Gynaecologists of India (2025), as well as Vitabiotics' winning the Queen's Award for Enterprise on four occasions. Having pioneered the new paradigm of nutraceutical therapy, Professor Lalvani poignantly observes that "while the last century was the century of antibiotics, this is the century of vitamins".

About Professor Tej Lalvani

Tej Lalvani has served as Chief Executive Officer of Vitabiotics for the last decade, having worked within the family business for more than 30 years, including previously as Chief Operating Officer. Under his leadership, Vitabiotics has rapidly scaled its position as the leading VMS player in the UK and on a global scale.

Outside of Vitabiotics, Tej Lalvani is widely recognised as an entrepreneur and investor, having appeared for five seasons as a Dragon on BBC's Dragons' Den. He has received multiple business and entrepreneurship awards, holds an Honorary Doctorate and Visiting Professorship for entrepreneurship and business from the University of Westminster, and was recently inducted into the Great British Entrepreneur Awards Hall of Fame.

Notes to Editors:
*Nielsen GB ScanTrack Value and Unit Sales 52 w/e 4th October 2025
**Certain group entities operating in jurisdictions outside the scope of this transaction will continue to trade under the existing beneficial ownership structure and are not part of the acquisition.